Granules unit gets USFDA nod for generic drug

Granules India has secured tentative approval from the USFDA for its generic ADHD medication. This approval is for Amphetamine extended-release orally disintegrating tablets. The drug is a generic version of Adzenys XR-ODT. It will be manufactured at Granules' US facility. The medication treats Attention Deficit Hyperactivity Disorder. This move strengthens Granules' presence in the Central Nervous System therapeutic area.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2xWXZ1P
via IFTTT